Anvisa approves new framework for clinical research rules in the country

News Healthcare & Pharma Law & Policy Updates

Date: 28th Nov, 2024 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

"On November 27, 2024, the Collegiate Board of Anvisa approved a broad update to the regulation that governs clinical research in Brazil. The new rules aim to increase the country's attractiveness for investments in clinical research, reducing bureaucratic hurdles and facilitating the development of medicines."

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Anvisa approves new framework for clinical research rules in the country

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Anvisa approves new framework for clinical research rules in the country

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.